QC Kinetix: A Regenerative Medicine Trailblazer Transforming the Medical Landscape

Revolutionizing Pain Relief and Recovery
QC Kinetix, an innovative and rapidly expanding regenerative medicine company, has redefined how patients approach joint and musculoskeletal pain relief. Since its founding in 2017, the company has grown exponentially, establishing clinics in over 100 cities and treating thousands with its cutting-edge, non-surgical therapies.

By utilizing regenerative medicine, QC Kinetix taps into the body’s natural healing capabilities, offering patients enhanced mobility and pain relief without surgery. This commitment to groundbreaking treatments has cemented its reputation as a leader in the medical field.

Recognized for Excellence in Growth and Innovation
In May 2024, QC Kinetix was honored as one of Entrepreneur magazine’s top 10 2024 Top New and Emerging Franchises, climbing to the No. 9 spot. The recognition was attributed to remarkable achievements in unit growth, financial stability, and brand presence. With an astonishing 2,111% growth in units over three years, QC Kinetix stands among the top brands reshaping patient care.

“We’re honored to rank among some of the fastest-growing franchise brands,” stated the CEO. “This acknowledgment reflects the dedication of our team and the impact we’re making in regenerative medicine.”

Expert Leadership and Visionary Collaboration
QC Kinetix recently brought on board Dr. Mitchell Sheinkop, a renowned orthopedic surgeon with over 37 years of experience, as the national medical director. His expertise and passion for regenerative medicine align perfectly with the company’s mission.

In his role, Dr. Sheinkop will lead the medical management team, refine treatment protocols, and oversee research and development to ensure QC Kinetix remains at the forefront of innovation. He also plans to integrate physical therapy and weight loss programs into the company’s offerings, further enhancing patient outcomes.

Under Dr. Sheinkop’s guidance, QC Kinetix enters an exciting new chapter, marked by groundbreaking advancements and a continued focus on superior patient care.

Celebrity Endorsement and Patient Advocacy
Pro Football Hall of Famer Emmitt Smith proudly serves as QC Kinetix’s national spokesperson, highlighting the company’s ability to help individuals maintain active lifestyles. “I’ve got to keep taking care of these joints,” Smith shared, emphasizing the transformative power of QC Kinetix’s treatments.

A Unique Approach to Regenerative Medicine
The company’s name reflects its mission: “QC” honors its Charlotte, North Carolina roots (the Queen City), and “Kinetix” symbolizes movement and energy. QC Kinetix focuses on restoring patients’ quality of life using regenerative therapies that bypass traditional medications, steroid injections, and invasive surgeries.

With a concierge medical model, the company prioritizes research-backed treatments that aren’t dictated by insurance limitations. A company spokesperson explained, “Our mission is to make QC Kinetix the first option for pain management, not just an alternative.”

Milestones and Vision for the Future
Since its national expansion in 2021, QC Kinetix has achieved significant milestones, including serving over 40,000 patients and surpassing $100 million in system-wide sales in 2023.

“It is our goal to change medicine,” said the CEO. “We aim to be the first choice for anyone dealing with pain. Seeing how we’ve changed patients’ lives is the ultimate measure of our success.”

Global Expansion and Future Goals
Building on its success, QC Kinetix is preparing for international growth, with plans to enter markets in the UK, Australia, and New Zealand. The company also aims to operate 250 locations in the United States by the end of 2024, further solidifying its leadership in regenerative medicine.

This rapid growth reflects the increasing demand for non-surgical pain relief and positions QC Kinetix as a game-changer in the medical industry. “I love this brand and our future,” the CEO concluded. “It’s about impacting people’s lives and redefining the possibilities in healthcare.”